Company Presentations
| Tuesday, October 21, 2025 |
| 12:30 PM - 1:25 PM |
Details
Chair: Rosanne Hyland, Deputy Chief Executive Officer, AusBiotech
Arovella Therapeutics - Michael Baker, Chief Executive Officer & Managing Director
ISOBiotech - Elizabeth Edrich, Chief Executive Officer
Neuroscientific Biopharmaceuticals - Nathan Smith, Chief Executive Officer
QBiotics Group Ltd - Ebru Davidson, General Counsel
Invion - Thian Chew, Executive Chair & Chief Executive Officer
Q&A